We are live on ! Find out more
PODD icon

Insulet

239 hedge funds and large institutions have $5.52B invested in Insulet in 2018 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 80 increasing their positions, 85 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 20

68% more call options, than puts

Call options by funds: $14.7M | Put options by funds: $8.75M

12% more funds holding

Funds holding: 214239 (+25)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

0.93% less ownership

Funds ownership: 110.88%109.95% (-0.93%)

2% less capital invested

Capital invested by funds: $5.61B → $5.52B (-$93.3M)

6% less repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 85

Holders
239
Holders Change
+25
Holders Change %
+11.68%
% of All Funds
5.47%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.14%
New
45
Increased
80
Reduced
85
Closed
20
Calls
$14.7M
Puts
$8.75M
Net Calls
+$5.91M
Net Calls Change
-$1.24M

PODD Hedge Fund Activity: Q2 2018 in Review

239 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q2 2018, worth a combined $5.52B — down 1.7% from $5.61B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new PODD positions and 20 closed out — a net gain of 25 holders — while 80 added to existing stakes and 85 trimmed.

The largest buyer was William Blair Investment Management, opening a new position worth an estimated $107M. The largest seller was BlackRock, cutting an estimated $115M.

  • 239 institutional investors held Insulet (PODD) as of Q2 2018, up from 214 in Q1 2018.
  • Funds reported $5.52B of Insulet stock for Q2 2018, down 1.7% quarter-over-quarter.
  • 45 funds opened new Insulet positions in Q2 2018 and 20 closed out, a net change of +25 holders.
  • The largest Insulet buyer in Q2 2018 was William Blair Investment Management, an estimated $107M added.
  • The largest Insulet seller in Q2 2018 was BlackRock, an estimated $115M sold.

Based on aggregated 13F filings for Q2 2018.